EU Annex 1 in Full Effect: Are Manufacturers with EU Drug Product Prepared?

Annex 1 is an opportunity for industry to emphasize advanced technologies and for Pharma companies to speed up their processes and reduce human error. This webinar will discuss how the now in-vigor requirements impact your organization.

Subject area:
cGMP

Objectives (If applicable):
N/A

Target Audience (If applicable):
Quality, manufacturing, process development, scientists, quality regulatory

Share:
Global Benchmarking Tools (GBT) Category

02 Registration and Marketing Authorization (MA)

Region / Country

Global

Tags

Live Webcast
On-Demand
Registration Required

Cost

Varies

Share your learning opportunity!

To top